ICON PLC (ICLR) stock
ICLRNasdaqServices-Commercial Physical & Biological Research
$194.65−5.86 (-2.92%)
Close on Nov 13, 2026Market cap $14.90BP/E 33.5Yield –
ICON cash
Cash and short-term investments held at the end of each period.
ICON's cash was $808.98M at Sep 30, 2026. For fiscal 2025 it was $647.30M, up 20.1% from the year before. Over ten years it grew 13.0% a year on average. The highest annual figure on record is $842.03M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $647.30M | +20.1% |
| FY2024 | Dec 31, 2024 | $538.79M | +41.8% |
| FY2023 | Dec 31, 2023 | $380.06M | +30.8% |
| FY2022 | Dec 31, 2022 | $290.48M | -61.5% |
| FY2021 | Dec 31, 2021 | $753.93M | -10.5% |
| FY2020 | Dec 31, 2020 | $842.03M | +47.8% |
| FY2019 | Dec 31, 2019 | $569.90M | +25.0% |
| FY2018 | Dec 31, 2018 | $455.76M | +26.4% |
| FY2017 | Dec 31, 2017 | $360.45M | +38.3% |
| FY2016 | Dec 31, 2016 | $260.59M | +37.2% |
| FY2015 | Dec 31, 2015 | $189.90M | -12.1% |
| FY2014 | Dec 31, 2014 | $216.00M | -32.7% |
| FY2013 | Dec 31, 2013 | $320.84M | +68.7% |
| FY2012 | Dec 31, 2012 | $190.23M | +9.2% |
| FY2011 | Dec 31, 2011 | $174.18M | -31.9% |
| FY2010 | Dec 31, 2010 | $255.71M | +31.8% |
| FY2009 | Dec 31, 2009 | $194.03M | +232.4% |
| FY2008 | Dec 31, 2008 | $58.38M | -24.1% |
| FY2007 | Dec 31, 2007 | $76.88M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $808.98M | +72.5% |
| Q2 FY2026 | Jun 30, 2026 | $928.39M | +137.8% |
| Q1 FY2026 | Mar 31, 2026 | $765.16M | +45.3% |
| Q4 FY2025 | Dec 31, 2025 | $647.30M | +20.1% |
| Q3 FY2025 | Sep 30, 2025 | $468.89M | -32.6% |
| Q2 FY2025 | Jun 30, 2025 | $390.40M | -22.9% |
| Q1 FY2025 | Mar 31, 2025 | $526.70M | +32.3% |
| Q4 FY2024 | Dec 31, 2024 | $538.79M | +41.8% |
| Q3 FY2024 | Sep 30, 2024 | $695.51M | +120.8% |
| Q2 FY2024 | Jun 30, 2024 | $506.55M | +86.3% |
| Q1 FY2024 | Mar 31, 2024 | $398.04M | +41.4% |
| Q4 FY2023 | Dec 31, 2023 | $380.06M | +30.8% |
| Q3 FY2023 | Sep 30, 2023 | $315.02M | -48.4% |
| Q2 FY2023 | Jun 30, 2023 | $271.83M | -55.9% |
| Q1 FY2023 | Mar 31, 2023 | $281.53M | -49.8% |
| Q4 FY2022 | Dec 31, 2022 | $290.48M | -61.5% |
| Q3 FY2022 | Sep 30, 2022 | $610.87M | -39.5% |
| Q2 FY2022 | Jun 30, 2022 | $616.63M | -41.7% |
| Q1 FY2022 | Mar 31, 2022 | $560.81M | -40.6% |
| Q4 FY2021 | Dec 31, 2021 | $753.93M | -10.5% |
| Q3 FY2021 | Sep 30, 2021 | $1.01B | +42.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.06B | +78.0% |
| Q1 FY2021 | Mar 31, 2021 | $944.18M | +95.0% |
| Q4 FY2020 | Dec 31, 2020 | $842.03M | +47.8% |
| Q3 FY2020 | Sep 30, 2020 | $709.72M | +50.6% |
| Q2 FY2020 | Jun 30, 2020 | $593.83M | +37.7% |
| Q1 FY2020 | Mar 31, 2020 | $484.10M | +1.3% |
| Q4 FY2019 | Dec 31, 2019 | $569.90M | +25.0% |
| Q3 FY2019 | Sep 30, 2019 | $471.24M | -4.1% |
| Q2 FY2019 | Jun 30, 2019 | $431.28M | +15.6% |
| Q1 FY2019 | Mar 31, 2019 | $477.94M | +35.2% |
| Q4 FY2018 | Dec 31, 2018 | $455.76M | +26.4% |
| Q3 FY2018 | Sep 30, 2018 | $491.48M | +68.0% |
| Q2 FY2018 | Jun 30, 2018 | $373.00M | +18.4% |
| Q1 FY2018 | Mar 31, 2018 | $353.54M | +10.8% |
| Q4 FY2017 | Dec 31, 2017 | $360.45M | +38.3% |
| Q3 FY2017 | Sep 30, 2017 | $292.48M | – |
| Q2 FY2017 | Jun 30, 2017 | $314.92M | – |
| Q1 FY2017 | Mar 31, 2017 | $318.97M | – |
| Q4 FY2016 | Dec 31, 2016 | $260.59M | – |
See a number that looks wrong?